Stockscreener 앱 받기
1.58
3.25%
0.04
전일 마감가:
$1.54
열려 있는:
$1.57
하루 거래량:
145.61K
Relative Volume:
0.16
시가총액:
$84.61M
수익:
-
순이익/손실:
$-151.16M
주가수익비율:
-0.532
EPS:
-2.97
순현금흐름:
$-130.08M
1주 성능:
-6.47%
1개월 성능:
-27.06%
6개월 성능:
+198.37%
1년 성능:
+9.66%
1일 변동 폭
$1.54
$1.64
1주일 범위
$1.49
$1.68
52주 변동 폭
$0.404
$2.27
AIx 온콜로지 Stock (ALXO) Company Profile
명칭
Alx Oncology Holdings Inc
전화
650-466-7125
주소
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO
ALXO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALXO
Alx Oncology Holdings Inc
|
1.58 | 82.47M | 0 | -151.16M | -130.08M | -2.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.56 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
641.11 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
430.09 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.14 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.19 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
AIx 온콜로지 Stock (ALXO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-06 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-12-19 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-03-08 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-12-08 | 업그레이드 | Jefferies | Hold → Buy |
| 2021-12-22 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-09-30 | 개시 | Stifel | Buy |
| 2021-05-05 | 재개 | Credit Suisse | Outperform |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2021-04-06 | 개시 | UBS | Buy |
| 2021-02-10 | 개시 | H.C. Wainwright | Buy |
| 2020-08-11 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-08-11 | 개시 | Credit Suisse | Outperform |
| 2020-08-11 | 개시 | Jefferies | Buy |
| 2020-08-11 | 개시 | Piper Sandler | Overweight |
모두보기
AIx 온콜로지 주식(ALXO)의 최신 뉴스
Is ALX Oncology Holdings Inc. stock attractive for hedge fundsSell Signal & Technical Pattern Recognition Alerts - newser.com
Statistical indicators supporting ALX Oncology Holdings Inc.’s strengthRisk Management & Free High Accuracy Swing Entry Alerts - newser.com
Can ALX Oncology Holdings Inc. hit a new high this monthJuly 2025 Intraday Action & AI Forecasted Entry/Exit Points - newser.com
Analyzing recovery setups for ALX Oncology Holdings Inc. investorsJuly 2025 Setups & Safe Capital Growth Stock Tips - newser.com
Will ALX Oncology Holdings Inc. continue its uptrend2025 Support & Resistance & Fast Gaining Stock Reports - newser.com
How to build a dashboard for ALX Oncology Holdings Inc. stockJuly 2025 Highlights & Capital Protection Trade Alerts - newser.com
Can ALX Oncology Holdings Inc. stock attract ESG capital inflowsIPO Watch & Short-Term Swing Trade Alerts - newser.com
Key metrics from ALX Oncology Holdings Inc.’s quarterly dataTrade Risk Assessment & Low Risk High Reward Ideas - newser.com
Will ALX Oncology Holdings Inc. stock reach Wall Street targetsJuly 2025 Spike Watch & Real-Time Chart Breakout Alerts - newser.com
ALX Oncology Holdings Inc. (ALXO) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Will ALX Oncology Holdings Inc. outperform the marketWeekly Volume Report & Weekly Breakout Opportunity Watchlist - newser.com
Will ALX Oncology Holdings Inc. benefit from macro trendsChart Signals & High Win Rate Trade Alerts - newser.com
Is ALX Oncology Holdings Inc. stock a buy before product launches2025 Breakouts & Breakdowns & Safe Entry Zone Tips - newser.com
Visual analytics tools that track ALX Oncology Holdings Inc. performanceRecession Risk & AI Optimized Trade Strategies - newser.com
Analyzing ALX Oncology Holdings Inc. with risk reward ratio charts2025 Volatility Report & Stepwise Swing Trade Plans - newser.com
Building trade automation scripts for ALX Oncology Holdings Inc.Trade Entry Report & Consistent Profit Alerts - newser.com
ALX Oncology (ALXO) Expected to Announce Earnings on Thursday - MarketBeat
ALX Oncology to Report Third Quarter 2025 Financial Results and Pipeline Progress Including Evorpacept CD47 Biomarker Data to be Presented at Upcoming SITC Annual Meeting - The Manila Times
ALX Oncology (NASDAQ: ALXO) to review biomarker data at SITC, report Q3 2025 results - Stock Titan
ALX Oncology’s ASPEN-09 Study: A Promising Update for Cancer Treatment - MSN
AIx 온콜로지 (ALXO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
AIx 온콜로지 주식 (ALXO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Lettmann Jason | CHIEF EXECUTIVE OFFICER |
Sep 16 '25 |
Buy |
1.07 |
21,070 |
22,461 |
233,958 |
| Shantharam Harish | Chief Financial Officer |
Aug 18 '25 |
Buy |
0.78 |
75,000 |
58,402 |
75,000 |
| Pinto Shelly | SVP, FINANCE AND CAO |
Aug 15 '25 |
Sale |
0.64 |
611 |
391 |
89,198 |
| Lettmann Jason | CHIEF EXECUTIVE OFFICER |
Aug 15 '25 |
Sale |
0.64 |
2,382 |
1,525 |
212,888 |
| Pinto Shelly | SVP, FINANCE AND CAO |
Jul 07 '25 |
Sale |
0.45 |
2,011 |
905 |
86,809 |
| Pinto Shelly | SVP, FINANCE AND CAO |
Jun 30 '25 |
Sale |
0.43 |
1,532 |
659 |
88,820 |
| Pinto Shelly | SVP, FINANCE AND CAO |
Feb 19 '25 |
Sale |
1.15 |
550 |
633 |
87,352 |
| Pons Jaume | PRESIDENT & CSO |
Feb 19 '25 |
Sale |
1.15 |
1,326 |
1,525 |
579,388 |
| Lettmann Jason | CHIEF EXECUTIVE OFFICER |
Feb 19 '25 |
Sale |
1.15 |
2,159 |
2,483 |
170,270 |
| Pinto Shelly | Interim CFO |
Jan 06 '25 |
Sale |
1.80 |
2,221 |
3,998 |
87,902 |
0.19%
1.82%
자본화:
|
볼륨(24시간):